Department of Veterans Affairs

Company

Related News

Compass Pathways highlights FDA Breakthrough designation as Trump orders faster psychedelic reviews

May 18, 2026

Compass Pathways said COMP360 for treatment-resistant depression retains FDA Breakthrough Therapy designation as it advances in phase 3. A Trump executive order also directs faster federal review of psychedelic drugs with breakthrough status.

AI workflow predicts colorectal cancer risk in ulcerative colitis with 99% accuracy

Apr 04, 2026

A study published on February 17, 2026 validated an AI workflow that predicted colorectal cancer risk in ulcerative colitis with 99% accuracy using over 55,000 patient records. The model identified low-risk and higher-risk patients from clinical notes, colonoscopy reports, and pathology findings.